Thierry Fontanges

2.3k total citations
27 papers, 508 citations indexed

About

Thierry Fontanges is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Thierry Fontanges has authored 27 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 13 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Thierry Fontanges's work include Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (9 papers). Thierry Fontanges is often cited by papers focused on Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (9 papers). Thierry Fontanges collaborates with scholars based in France, Germany and Australia. Thierry Fontanges's co-authors include Denis Ouzan, P. Chossegros, Fabien Zoulim, Janice K. Albrecht, Carlton Meschievitz, Xavier Causse, C. Trépo, P. Mélin, P. Cacoub and Michel Rotily and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Thierry Fontanges

26 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Fontanges France 11 408 375 78 53 46 27 508
P. Marks United Kingdom 7 223 0.5× 195 0.5× 55 0.7× 19 0.4× 60 1.3× 17 316
G. Pinzello Italy 10 376 0.9× 367 1.0× 73 0.9× 6 0.1× 12 0.3× 17 455
Margarita Dehesa-Violante Mexico 11 160 0.4× 175 0.5× 11 0.1× 33 0.6× 28 0.6× 24 314
Elena Vezali Greece 10 184 0.5× 217 0.6× 15 0.2× 44 0.8× 22 0.5× 18 319
Sylvia Dražilová Slovakia 12 255 0.6× 274 0.7× 18 0.2× 9 0.2× 17 0.4× 45 441
Stefan Bourgeois Belgium 11 540 1.3× 535 1.4× 24 0.3× 9 0.2× 124 2.7× 49 708
Carmen Landaverde United States 12 354 0.9× 327 0.9× 16 0.2× 15 0.3× 41 0.9× 34 458
C. Cancellieri Italy 5 240 0.6× 254 0.7× 7 0.1× 45 0.8× 23 0.5× 12 339
Richard Manch United States 9 229 0.6× 199 0.5× 14 0.2× 9 0.2× 24 0.5× 21 348
Rohit Satoskar United States 11 178 0.4× 135 0.4× 7 0.1× 30 0.6× 40 0.9× 33 358

Countries citing papers authored by Thierry Fontanges

Since Specialization
Citations

This map shows the geographic impact of Thierry Fontanges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Fontanges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Fontanges more than expected).

Fields of papers citing papers by Thierry Fontanges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Fontanges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Fontanges. The network helps show where Thierry Fontanges may publish in the future.

Co-authorship network of co-authors of Thierry Fontanges

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Fontanges. A scholar is included among the top collaborators of Thierry Fontanges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Fontanges. Thierry Fontanges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Causse, Xavier, Pascal Potier, Antoine Valéry, et al.. (2024). Predictive Factors for HBsAg Loss in Chronic HBeAg‐Negative Hepatitis B Virus Infection: Insights From a 5‐Year French Cohort. Journal of Viral Hepatitis. 32(1). e14041–e14041. 1 indexed citations
2.
Testoni, Barbara, Armando Andres Roca Suarez, Marie‐Laure Plissonnier, et al.. (2023). Evaluation of the HBV liver reservoir with fine needle aspirates. JHEP Reports. 5(10). 100841–100841. 11 indexed citations
3.
Fontanges, Thierry, et al.. (2011). 5‐Fluorouracil—Induced Tako‐Tsubo—Like Syndrome. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(2). 226–226. 51 indexed citations
4.
Marcellin, Patrick, M Chousterman, Thierry Fontanges, et al.. (2011). Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver International. 31(4). 516–524. 58 indexed citations
5.
Mélin, P., M Chousterman, Thierry Fontanges, et al.. (2010). Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study. European Journal of Gastroenterology & Hepatology. 22(9). 1050–1057. 33 indexed citations
6.
Marcellin, Patrick, Jean‐François Cadranel, Thierry Fontanges, et al.. (2010). High rate of adefovir–lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France. European Journal of Gastroenterology & Hepatology. 22(11). 1290–1296. 4 indexed citations
7.
8.
Fontanges, Thierry, François Bailly, Eric Trépo, et al.. (2008). Discordance between biochemical markers of liver activity and fibrosis (Actitest®–Fibrotest®) and liver biopsy in patients with chronic hepatitis C. Gastroentérologie Clinique et Biologique. 32(10). 858–865. 12 indexed citations
9.
Cacoub, P., Denis Ouzan, P. Mélin, et al.. (2008). Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study. World Journal of Gastroenterology. 14(40). 6195–6195. 29 indexed citations
10.
Trépo, Christian, Anne-Marie Marion-Audibert, Didier Samuel, Dominique Guyader, & Thierry Fontanges. (2008). [Maintenance therapy for chronic hepatitis C].. PubMed. 31(8-9 Pt 3). 4S29–33. 2 indexed citations
11.
12.
Cadranel, Jean–François, Marc Bourlière, Thierry Fontanges, et al.. (2007). Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study. Gastroentérologie Clinique et Biologique. 31(2). 180–184. 6 indexed citations
13.
Fontanges, Thierry, Sylvain Béorchia, Catherine Douvin, et al.. (2007). Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection. Gastroentérologie Clinique et Biologique. 31(6-7). 566–572. 13 indexed citations
14.
Marcellin, Patrick, J.F. Cadranel, Thierry Fontanges, et al.. (2007). [509] WHICH PATIENTS WITH CHRONIC HEPATITIS B ARE TREATED AND HOW: A CROSS-SECTIONAL STUDY IN FRANCE ON 1790 PATIENTS. Journal of Hepatology. 46. S194–S194. 1 indexed citations
15.
Trépo, Christian, Anne-Marie Marion-Audibert, Didier Samuel, Dominique Guyader, & Thierry Fontanges. (2007). Traitement d’entretien. Gastroentérologie Clinique et Biologique. 31(8-9). 29–33. 2 indexed citations
16.
Roudot‐Thoraval, Françoise, Armand Abergel, François‐André Allaert, et al.. (2001). [Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences].. PubMed. 25(12). 1061–6. 9 indexed citations
17.
Broussolle, E., et al.. (1993). [Treatment of Wilson's disease with zinc. 5 cases].. PubMed. 149(6-7). 393–7. 3 indexed citations
18.
Causse, Xavier, P. Chossegros, Fabien Zoulim, et al.. (1991). Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology. 101(2). 497–502. 222 indexed citations
19.
Trépo, Christian, Denis Ouzan, Thierry Fontanges, et al.. (1986). Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection. Journal of Hepatology. 3. S129–S135. 7 indexed citations
20.
Trépo, C., Denis Ouzan, Thierry Fontanges, et al.. (1986). Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV. Journal of Hepatology. 3. S97–S105. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Marks Breakdown of academic impact, for papers by G. Pinzello Breakdown of academic impact, for papers by Margarita Dehesa-Violante Breakdown of academic impact, for papers by Elena Vezali Breakdown of academic impact, for papers by Sylvia Dražilová Breakdown of academic impact, for papers by Stefan Bourgeois Breakdown of academic impact, for papers by Carmen Landaverde Breakdown of academic impact, for papers by C. Cancellieri Breakdown of academic impact, for papers by Richard Manch Breakdown of academic impact, for papers by Rohit Satoskar
Rankless by CCL
2026